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ABSTRACT
Two pharmacokinetic methods are used primarily to assess sys-
tematic bioavailabilityoforallydosedwater-solublecompounds
in vivo, but there have been no direct comparisons of the
estimates obtained. The “area under the curve” (AUC) method
employs a single oral dose of probe compound(s) followed by
multiple blood sampling to obtain plasma concentration time
curves. Separate injection of probe(s) followed by multiple
blood sampling is used to calculate fractional elimination rate
(Kel) and distribution pool space (S). The “steady state feeding”
method relies on ad lib. feeding of a marked diet, with a single
blood sample taken to measure steady state feeding concen-
tration of probe(s); Kel is estimated from the decline in probe
concentration in excreta after injection, with a single blood
sample taken to estimate S. We compared these methods di-
rectly in the Australian red wattlebird (Anthochaera carnun-
culata), measuring absorption of
3H-l-glucose. The Kel values
estimated using the steady state feeding protocol were signiﬁ-
cantly higher, and estimates of S and bioavailability conse-
quently lower, compared with the AUC protocol. The AUC
method relies on fewer assumptions and allows simultaneous
comparisons of absorption by mediated and nonmediated (i.e.,
paracellular) mechanisms but cannot be easily applied to freely
feeding animals. The steady state feeding method allows work
with smaller species and exploration of the effects of feeding
on nutrient uptake but requires careful attention to the validity
of assumptions that increase error in the calculations.
Introduction
Water-soluble nutrients such as carbohydrates and amino acids
are absorbed in the small intestine by both protein carrier-
mediated (transcellular; e.g., via the Na
-glucose cotransporter
SGLT1) and nonmediated (i.e., paracellular) mechanisms
(Hopfer 1987). Paracellular uptake involves transfer between
epithelial cells, across the tight junctions that constrain the
movement of water and hydrophilic solutes between the cells
(Ballard et al. 1995; Anderson 2001). The nutritional signiﬁ-
cance of paracellular absorption was the subject of debate in
the past, in part because differences in methodologymadecom-
parisons across studies and species problematic (McWhorter
2005). Paracellular transport of glucose appears to account for
a relatively small proportion of total glucose uptake (∼5%) in
nonﬂying mammals such as rats (O’Rourke et al. 1995; Uhing
and Kimura 1995), dogs (Lane et al. 1999; Pencek et al. 2002,
2003), and humans (Fine et al. 1993). Recent studies using
uniform methodology have shown convincingly, however, that
small birds (Karasov and Cork 1994; Levey and Cipollini 1996;
Aﬁk et al. 1997; Chediack et al. 2001, 2003; Chang and Karasov
2004; Napier et al. 2008b) and bats (Tracy et al. 2007; Caviedes-
Vidal et al. 2008) rely extensively on nonmediated mechanisms
of absorption. In these animals, paracellular nutrient uptake
supplements carrier-mediated absorption, allowing them to
maintain high digestive efﬁciency in spite of generally smaller
intestines, lower absorptive surface area, and relatively rapid
digesta throughput (Caviedes-Vidal et al. 2007).
Absorption of small, nontransported, metabolically inert,
water-soluble probe molecules (e.g., stereoisomers of simple
sugars such as l-glucose) is used to assess paracellular nutrient
absorption (Chang et al. 2004; McWhorter 2005; McWhorter
et al. 2006; Caviedes-Vidal et al. 2007; Napier et al. 2008a,
2008b). This typically involves measuring the fraction of an
oral dose of a probe that reaches the systemic circulation,
known as the “fractional absorption” or “systemic bioavail-
ability” (Gibaldi 1991). Measurement of in vivo rates of ab-
sorption of paracellular probes relative to compounds absorbed
via mediated mechanisms provides the most robust assessment
of the nutritional signiﬁcance of paracellular uptake (Chang
and Karasov 2004). The primary pharmacokinetic protocol
used to measure both extent and rate of absorption in vivo
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imental protocol) involves delivering probe(s) in a single dose
by oral gavage and separately by injection, followed by multiple
blood samples to obtain blood plasma marker concentration
time curves (Gibaldi and Perrier 1982). The requirement for
multiple blood samples over a short period of time restricts
the use of this approach to animals above a certain body mass
(∼60 g in birds).
A second pharmacokinetic protocol estimates the bioavail-
ability as animals are feeding ad lib. at steady state on a diet
containing the marked probe(s) (hereafter termed the “steady
state feeding” experimental protocol). Fractional probe elimi-
nation rate and distribution pool size must be assessed after
intramuscular or intravenous injection, which can be carried
out simultaneously with steadystatefeedingbyusingalternately
radiolabeled compounds or in a separate experimental trial.
This may be done by measuring probe concentration in mul-
tiple small blood samples over time after injection or, making
additional assumptions,basedonmarkerappearanceinexcreta.
This method allows only calculation of bioavailability but has
the advantage that when elimination is assessed based on
marker appearance in excreta, only one or two blood samples
are required (depending on whether absorption and elimina-
tion parameters are measured simultaneously or in separate
trials), allowing the method to be applied in animals that are
too small to allow multiple blood sampling. Furthermore, the
protocol allows for manipulation of the diet the animal is feed-
ing on, allowing assessment of the effects of diet energy density
or nutrient concentration on absorption. Since its adaptation
by Karasov and Cork (1994), the steady state feeding method
has been the protocol of choice for assessing paracellular nu-
trient absorption in small species (McWhorter et al. 2006) and
has also been adapted for studying intestinal water absorption
and renal function (McWhorter and Martı ´nez del Rio 1999;
McWhorter et al. 2003, 2004; Hartman Bakken et al. 2004;
Hartman Bakken and Sabat 2006).
Where the rate of probe elimination is to be assessed from
its rate of appearance in excreta, an important assumption is
that the rate of loss of marker from plasma equals that of its
appearance in excreta (Karasov and Cork 1994; Hartman Bak-
ken et al. 2004). Karasov and Cork (1994) showed that this
was the case in nectarivorous rainbow lorikeets (Trichoglossus
haematodus) by sampling both blood and excreta in the same
birds after probe injection. Although the method has been
widely used over the intervening years (e.g., McWhorter and
Martı ´nez del Rio 1999; McWhorter et al. 2003, 2004; Chang
et al. 2004; Chang and Karasov 2004; Hartman Bakken et al.
2004; Hartman Bakken and Sabat 2006; Napier et al. 2008b),
this assumption has not been tested in any species other than
the rainbow lorikeet. There has been no direct comparison of
these two pharmacokinetic protocols in the same species. In
particular, we have no assessment of differences in pharma-
cokinetic parameters and bioavailability estimates generated.
The aim of our study, therefore, was to compare these two
experimental protocols in the nectarivorous redwattlebird(An-
thochaera carnunculata, Meliphagidae), examining the meth-
odology, assumptions, and beneﬁts of each pharmacokinetic
method.
We selected the red wattlebird because it is sufﬁciently large
to allow repeated blood sampling to be carried out. We have
also compared the digestive handling of sugars by the red wat-
tlebird and rainbow lorikeet (the latter species examined by
Karasov and Cork in establishment of the steady state feeding
method) and recorded substantial differences between the spe-
cies (Napier et al. 2008a). In rainbow lorikeets, the bioavaila-
bility of d-glucose calculated using the standard AUC phar-
macokinetic protocol was not signiﬁcantly different from
apparent assimilation efﬁciency calculated using a traditional
mass-balance approach (Napier et al. 2008a) or from estimates
based on the steady state feeding pharmacokinetic protocol
(Karasov and Cork 1994). However, in the red wattlebird, es-
timated bioavailability of d-glucose using the AUC protocol
was erroneously low (∼57%), did not match apparent assim-
ilation efﬁciency values established through mass-balance ap-
proach (∼99%), and logically should have exceeded values for
the bioavailability of l-glucose (estimated at 92%–96%; Napier
et al. 2008a). The erroneously low values for bioavailability of
d-glucose were interpreted as presystemic catabolism and/or
sequestering of the marker in tissues, subsequently conﬁrmed
by using 3-O-methyl-d-glucose (∼90%), a nonmetabolizable
d-glucose analogue that competes for the same cotransporters
as d-glucose (Napier et al. 2008a). The appearance of l-glucose
in the bloodstream is also exceptionally fast in red wattlebirds:
values had already peaked by the ﬁrst blood sample at 2.5–5
min while the peak for l-glucose absorption in rainbow lori-
keets was recorded around 45 min. These results highlight sub-
stantial differences in digestive handling of sugars by two nec-
tarivorous birds of similar body size and are sufﬁcient to
warrant revisitation of the assumptions of the pharmacokinetic
methodologies. We undertook this study to directly compare
the two pharmacokinetic protocols and to determine whether
the assumptions of the steady state feeding protocol can be
correctly applied to nectarivorous birds, which have high rates
of carbohydrate digestion and assimilation.
Material and Methods
Birds and Their Maintenance
Seven red wattlebirds (Anthochaera carnunculata, mean body
mass g, g) were captured on m p 108 8 range p 98–114 b
the grounds of Murdoch University, Perth, Western Australia,
by mist netting in August 2007. Birds were housed inindividual
cages (46 cm # 56 cm # 45 cm) in a controlled-environment
room maintained at on a 12-h automatic lighting 212C
regime with the photophase from 0600 to 1800 hours. Wattle-
birds were fed a maintenance diet ad lib. consisting of Wom-
baroo powder(mainsugartypepresentwassucrose;Wombaroo
Food Products, Adelaide, South Australia) supplemented with
additional sucrose (total content of ca. 25% w/w dry matter),
mixed with water in inverted, stoppered syringes. Birds were
acclimated to captivity and experimental conditions (i.e., han-
dled regularly and exposed to experimental cages) for at least202 K. R. Napier, T. J. McWhorter, and P. A. Fleming
3 wk before experiments. Experiments were separated by at
least a week to ensure birds recovered from repeated blood
samples and maintained weight. Body mass did not change
signiﬁcantly between trials. During experiments, birds were
housed individually in opaque plastic cages (42 cm # 54
cm # 50 cm) with an automatic lighting regime as above and
a one-way mirror to minimize disturbance during collection
of excreta. All animal care procedures and experimental pro-
tocols adhered to Murdoch University Animal Ethics Com-
mittee regulations (AEC protocol R1137/05).
General Methods
In accordance with multiple previous studies (e.g., Karasov and
Cork 1994; Chang et al. 2004; Chang and Karasov 2004), we
used radiolabeled l-glucose, an isomer of d-glucose that is
biologically inert, not metabolized, andnotabsorbedbycarrier-
mediated mechanisms (Karasov and Cork 1994; Chang and
Karasov 2004; McWhorter 2005). l-glucose bioavailability was
estimated using
3H-l-glucose administered orally (by oral ga-
vage or ad lib. feeding) and by intramuscular (IM) injection
to each bird. The order of treatment given was randomly as-
signed within each experimental protocol, and each bird was
tested with both methods. The quantity of solution adminis-
tered by IM injection, oral gavage, or ad lib. feeding was mea-
sured by weighing the syringe or feeder before and after ad-
ministration (0.00001 g). Aliquot samples of all radiolabeled
solutions were transferred to scintillation vials. Excreta samples
were collected in glass microcapillary tubes immediately after
being voided by birds, with exact time of excretion noted, and
transferred to scintillation vials. Blood samples were collected
in standard heparinized microhematocrit tubes, which were
sealed with Cha Seal clay tube sealing compound (Chase Sci-
entiﬁc Glass, Rockwood, TN), and centrifuged for 2–3 min at
∼9,000 g; harvested plasma samples were transferred to scin-
tillation vials. All scintillation vials were weighed before and
after addition of samples (0.00001 g); 3 mL of liquid scin-
tillation ﬂuid was added (Ecolite, MP Biomedicals Austral-
asia, Seven Hills, New South Wales), and then vials were
counted in a scintillation spectrometer (Beckman LS6500 Liq-
uid Scintillation Counter, Beckman Coulter, Fullerton, CA) for
disintegrations per minute (dpm). These values were later nor-
malized to sample mass (i.e., dpm [mg sample]
1).
Assessment of l-Glucose Bioavailability Based on the
AUC Protocol
This method relies on single-dose administration of the
probe(s) followed by a series of blood samples.
3H-l-glucose
was administered to red wattlebirds by oral gavage and IM
injection in separate experiments, separated by at least 2 wk to
ensure complete recovery from the process of repeated blood
collection. Measurements began approximately2.5hafterlights
on. Maintenance diet was removed 20 min before the
experiments.
Oral Administration. Birds were gavaged with 300 mL of a so-
lution containing 1.665 MBq of
3H-l-glucose, 200 mmol L
1
unmarked d-glucose, and 75 mmol L
1 of NaCl, conditions
relatively saturating for the mediated Na
-glucose cotranspor-
ter, SGLT1 (Chang and Karasov 2004).
IM Administration. To determine the elimination rate constant
(Kel, min
1) and probe distribution pool size (S, mg plasma)
of
3H-l-glucose, birds were injected into the pectoralis muscle
with 125 mL of a solution containing 0.8325 MBq of
3H-l-
glucose and 175 mmol L
1 NaCl. The total osmolality of in-
jection solutions was controlled at about 350 mmol kg
1 so
that the solutions were approximately isosmotic with avian
blood (Goldstein and Skadhauge 2000). The values of Kel and
S were derived for each individual bird by linear ﬁtting of ln-
transformed plasma
3H-l-glucose concentration (Ci) over time
after IM administration (ti), with Kel estimated from the slope
of the line and S estimated from the y-intercept of the plasma
plots, according to Karasov and Cork (1994).
For both oral and IM administration, a brachial vein blood
sample (∼50 mL) was collected before probe administration for
background correction (t0). Eight blood samples were similarly
collected at times 2.5, 5, 10, 20, 30, 45, 60, and 120 min after
administration. After the ﬁrst hour of blood sampling (during
which the birds were held in the hand and periodically offered
maintenance diet from a feeder), birds were transferred to an
experimental cage and received maintenance diet ad lib.
Bioavailability (f) was calculated by two methods (Gibaldi
and Perrier 1982; Welling 1986). Equation (1) was required for
comparison with the steady state feeding experiments, but
equation (2) is the more traditional method for estimating
bioavailability from repeated blood samples:
AUCoral f p #K #S,( 1 ) el dose
AUC /dose oral f p ,( 2 )
AUC /dose IM
where AUCoral and AUCIM are the areas under the probe plasma
concentration (Ci) versus time (t) curve for oral and IM treat-
ments, respectively. The extent of absorptionoftheradiolabeled
probe from t0 to the last sampling point at 120 min (tn)i s
represented by the area under the curve for this time period
(AUCtn), estimated as
tn n1t t i1 i AUCt p Cdt p (C C ). (3)  n  ii 1 2 ip0 t0
The total area under the curve (AUCtotal) represents the total
amount of radiolabeled probe absorbed from time zero (t0)t o
time inﬁnity (t). To extrapolate to t requires the calculation
of AUCtnr, which is estimated as
Cn AUCt p ,( 4 ) nr Kel
where Kel is the elimination rate constant derived for each in-Technical Comment 203
dividual bird by linear ﬁtting of ln-transformed plasma
3H-l-
glucose concentration as described above.
Assessment of l-Glucose Bioavailability Based on the
Steady State Feeding Protocol
The bioavailability of l-glucose was calculated as (Karasov and
Cork 1994)
P#K #S el f p .( 5 )
I
The ingestion rate of radiolabeled l-glucose in food (I, dpm
min
1) and the steady state concentration of radiolabel in
plasma (P, dpm [mg plasma]
1) weredeterminedthroughfeed-
ing trials, whereas the probe distribution pool size (S,m g
plasma) and the elimination rate constant for removal of ra-
diolabel (Kel, min
1) were determined based on elimination of
the radiolabel after IM injection. It is possible to collect data
for all parameters simultaneously by using alternate radiolabels
(e.g.,
3H- and
14C-l-glucose as per Karasov and Cork 1994),
but in our study feeding and injection trials were conducted
separately (separated by at least 1 wk), both using
3H-l-glucose.
Before the commencement of the experiments, birds were al-
lowed to feed ad lib. on a 400 mmol L
1 d-glucose diet for at
least 6 h.
Oral Administration. Feeding trials commenced at 1500 hours
when the bird was weighed and the unmarked diet solution
was replaced with a syringe containing the equivalent diet that
included 0.222 MBq mL
13 H-l-glucose. The ingestion rate of
radiolabeled l-glucose (I, dpm min
1) was calculated from
changes in the mass of the feeder syringe, with the exact time
interval recorded for each individual bird from the moment
feeding began until birds were removed from the cage to take
a blood sample (∼3 h). Fresh excreta samples were collected at
10–15-min intervals for up to 3 h after oral administration to
verify that the birds had reached steady state with regard to
the absorption and excretion of the radiolabeled l-glucose. The
steady state feeding concentration of radiolabeled l-glucose in
plasma (P, dpm [mg plasma]
1) was determined in a single
∼50-mL blood sample taken from the brachial vein after birds
had been feeding on the marked diet for approximately 3 h
(exact time recorded for each bird).
IM Administration. At 1600 hours, each bird was weighed and
then injected into the pectoralis muscle with 50 mL of solution
containing 1.665 MBq of
3H-l-glucose and 175 mmolL
1NaCl.
Birds were then allowed to feed ad lib. on unmarked 400 mmol
L
1 d-glucose diet. Fresh excreta samples were collected im-
mediately after being voided by birds (noting the exact time)
for approximately 2 h after IM administration, and a single
∼50-mL blood sample was taken at the end of the excreta col-
lection period.
The value of Kel for the steady state feeding method was
derived for each individual bird by three methods. First, Kel
was estimated as the linear slope of ln-transformed excreta l-
glucose concentrations over time after IM administration (Kar-
asov and Cork 1994; method A). Second, Kel was estimated
from nonlinear curve ﬁtting of excretal-glucoseconcentrations
(not ln-transformed) over time (method B), or, third, these
data were edited to remove some initial data points for each
individual where the differences between consecutive excreta
l-glucose concentrations (dpm [mg excreta]
1) were at least
ﬁve times higher than the differences between subsequent data
points and nonlinear curve ﬁtting was repeated (method C).
This method of editing initial data may be justiﬁed because of
disturbance of birds after handling for injections: these data
may be unreliable since some individuals do not immediately
return to normal rates of feeding and excretion, resulting in
erratic and erroneous initial excreta marker concentrations that
do not meet the required assumptions of normality and con-
stant variance for model ﬁtting. We estimated S using Kel values
calculated based on appearance of marker in excreta coupled
with marker concentration in the single blood sample to cal-
culate the theoretical l-glucose concentration at t0, which was
then inversed to obtain distribution space (McWhorter et al.
2006).
Statistical Analysis and Nonlinear Curve Fitting
Nonlinear curve ﬁtting by the Marquardt-Levenberg algorithm
(SYSTAT Software, SigmaPlot for Windows, San Jose, CA; Mar-
quardt 1963) was used to assess plasma or excreta l-glucose
elimination data. The following mono-andbiexponentialmod-
els were compared when analyzing the curves of concentrations
(C)o fl-glucose over time (t), where C0 is the intercept (dpm
[mg plasma]
1):
Kt el C p Ce ,( 6 ) 0
at bt C p ae be .( 7 )
Model ﬁts were compared by F-tests according to Motulsky
and Ransnas (1987), where the residual sum of squares and
the numbers of parameters in each model are used to compute
the F ratio, which tests for signiﬁcant differences in the good-
ness of ﬁt of the two models to the same data. We report the
largest F values and the smallest P values of the six individual
birds in each case.
Numerical data are presented as ( meanSD n p number
). Although the data shown in ﬁgure 1a are mean of animals
values, all calculations and statistical analyses were performed
on data for individual birds. Bioavailability and other propor-
tional data were arcsine square root transformed before statis-
tical analysis (Sokal and Rohlf 1995). Results were analyzed by
repeated-measures ANOVA. Statistical signiﬁcance was ac-
cepted at . a ! 0.05204 K. R. Napier, T. J. McWhorter, and P. A. Fleming
Figure 1. a, Dose-corrected plasma
3H-l-glucose concentration
( , for all time points) as a function of time since mean SD n p 7
intramuscular (IM) injection and oral gavage. The area underthecurve
(AUC) values for each individual bird were used to calculate l-glucose
bioavailability (f). The fractional rate of elimination (Kel) of an intra-
muscular-injected dose of
3H-l-glucose was calculated using (b)
plasma
3H-l-glucose concentration for repeated blood samples at
ﬁxed time points (i.e., same data as for IM treatment in a, presented for
individual birds) or (c) under the steady state feeding protocol, using
the concentration of
3H-l-glucose in excreta as a function of time since
injection of the dose(alldata shown).Eachsymbolinbandcrepresents
a different individual bird ( ), and solid lines are least squares n p 7
linear ﬁts.
Results
Assessment of l-Glucose Bioavailability Based on the
AUC Protocol
Plasma l-glucose concentration equilibrated rapidly after IM
injection, with the average concentration in plasma peaking at
5 min, indicating little to no extended lag for distribution from
the pectoralis muscle into the blood (ﬁg. 1a). After IM ad-
ministration, the relationship between ln-transformed l-glu-
cose concentrations in plasma (dpm mg
1) versus time was
approximately linear ( , ; ﬁg. 1b), implying
2 R 1 0.94 P ! 0.001
single-compartment elimination kinetics. Single-compartment
elimination kinetics were subsequently conﬁrmed by nonlinear
curve ﬁtting; for six out of seven cases, l-glucose elimination
data did not ﬁt a biexponential model signiﬁcantly better than
a monoexponential model (for six cases, all , ). F ! 0.09 P 1 0.91
The elimination constant Kel and probe distribution space S
estimates derived from ln-transformed IM data are given in
table 1.
After oral gavage, average l-glucose concentration in plasma
peaked at 10 min (ﬁg. 1a) and declined exponentiallythereafter.
There was a signiﬁcant difference between dose-corrected
AUCoral and AUCIM ( ; table 1). l-glucose bioavail- P p 0.001
ability estimated by equation (1) ( ) was not sig- 75.0%7.6%
niﬁcantly different from that estimated by equation (2)
(; ) . 83.2%7.4% P p 0.18
Assessment of l-Glucose Bioavailability Based on the
Steady State Feeding Protocol
Average steady state feeding plasmal-glucoseconcentration(P)
was relatively high (table 1) in comparison to background (raw
values ranged from 320 to 1,365 dpm), indicating substantial
absorption of
3H-l-glucose. Steady state feeding was veriﬁed
by conﬁrming that
3H-l-glucose concentration in excreta was
constant over time when animals were feeding on the marked
diet. After animals had recovered from handling, all birds did
feed at a steady state with regard to radiolabel ingestion and
excretion by 90 min ( , ).
2 R ! 0.25 P 1 0.30
After IM administration, the relationship between ln-trans-
formed l-glucose concentrations from excreta (dpm mg
1)ve r -
sus time were approximately linear ( , ; ﬁg.
2 R 1 0.83 P ! 0.001
1c), implying single-compartment elimination kinetics for
3H-
l-glucose. The relationship between nonlinear curve ﬁtting of
excreta l-glucose concentrations (not ln-transformed) over
time was deemed to follow single-compartment elimination
kinetics (Motulsky and Ransnas 1987), whether using all of the
data (method B) or the edited data (method C).Technical Comment 205
Table 1: Parameters used to determine bioavailability (f)o f
3H-l-glucose using two pharmacokinetic protocols: area
under the curve (AUC) and steady state feeding (SSF)
AUC (eq. [1]) vs.
SSF (method A or C)
AUC
SSF
method SSF F
a P
AUCoral (dpm [mg plasma]
1 min) .00136  .000139
A
AUCIM (dpm [mg plasma]
1 min) .00164  .000093
B
Marker intake rate, I (dpm min
1) 994,000  298,000
Steady state plasma marker
concentration, P
(dpm [mg plasma]
1) 1,490  460
Elimination rate constant, Kel (min
1) .0250  .0030 A .0333  .0057
1 9.10 .023
B .0508  .0158
2
C .0281  .0056
1 1.16 .323
Probe distribution space, S
(mg plasma) 21,400  3,700 A 9,300  5,200
1 20.47 .004
B 2,900  2,700
2
C 18,800  14,100
1 .23 .651
Bioavailability, f (%):
Equation (1) 75.0  7.6 A 42.9  15.2
1 35.51 .001
Equation (2) 83.2  7.4 B 17.1  15.5
2
C 68.3  30.4
1 4.51 .078
Note. For AUC trials (0.2 mol L
1 d-glucose in gavage solution), f was calculated by two equations (no signiﬁcant difference in estimates of f;
, ) using the same parameters of Kel and S; there was a signiﬁcant difference in AUC between the administration routes (oral vs. F p 2.35 P p 0.176 1,6
intramuscular; , ). For SSF trials (0.4 mol L
1 d-glucose in diet ad lib.), parameters were calculated using linear ﬁtting to ln- F p 35.51 P p 0.001 1,6
transformed excreta
3H-l-glucose concentration data (method A) or nonlinear monoexponential model ﬁts of all nontransformed data (method B) or
edited data (method C, where the ﬁrst data points were selectively removed; see “Material and Methods”). Superscripts refer to signiﬁcant differences
between methods (uppercase letters: differences in AUC between the administration routes; numbers: differences between the three SSF methods).
Statistical signiﬁcance was determined by repeated-measures ANOVA, with signiﬁcance accepted at and shown in bold. Values are a ! 0.05 means 
() . SD n p 7
aFor all F,. df p 1,6
For method B, in ﬁve out of seven cases a biexponential
model did not ﬁt l-glucose elimination data signiﬁcantly better
than a monoexponential model ( , ). For F ! 1.27 P 1 0.30
method C, in six out of seven cases a biexponential model did
not ﬁt l-glucose elimination data signiﬁcantly better than a
monoexponential model ( , ). F ! 0.02 P 1 0.98
There were signiﬁcant differences in the estimates of Kel and
S derived through different methods and substantial differences
in the variability of these data according to the method of
calculation (see table 1 for values). Therefore, S values as a
percent of body mass also differed between the methods (AUC:
; SSF method A: ; method B: 19.67%3.01% 8.75%5.44%
; method C: ). 2.71%2.52% 17.3%12.4%
Comparison of Experimental Protocols
Values of Kel estimated as the slope of the relationship between
ln-transformed excreta l-glucose concentration versus time
(method A) derived through the steady state feeding protocol
were higher than those estimated from the AUC method (table
1; ). Subsequently, S ( ) and f for l-glucose P p 0.023 P p 0.004
( ) values were around half the values estimated from P p 0.001
the AUC method and were far less variable (table 1).
The use of nonlinear curve ﬁtting to raw excreta l-glucose
concentration values (method B) made these discrepancies far
worse (table 1), and only by selectively editing these data
(method C; see “Material and Methods” for criteria) were the
values similar to those estimated using the AUC method (table
1), although we note the high degree of variability in these
edited data.
Discussion
The number of studies that have applied thesteadystatefeeding
pharmacokinetic protocol has grown recently because this
method allows the researcher to work with small animals that
could not withstand repeated blood sampling. Despite its wide
application, there have been few studies that have critically
assessed whether studies in animals meet the assumptions of
the method or compare these data with those derived through
the standard AUC pharmacokinetic protocol. Fundamentally,
both protocols rely on the calculation of Kel. We found that Kel
was signiﬁcantly higher and S subsequently lower for the steady206 K. R. Napier, T. J. McWhorter, and P. A. Fleming
state feeding compared with the AUC protocol. Consequently,
estimates of l-glucose bioavailability derived from the steady
state feeding protocol were lower than estimates derived
through the AUC protocol (unless the data were selectively
edited). In this discussion, we explore the assumptions and
advantages of these methods.
In addition to being the more robust method of estimation,
the primary advantage of the AUC pharmacokinetic protocol
is that it allows simultaneous comparison of the extent and
rate of absorption of passively and actively absorbed probe
molecules in vivo (Chang and Karasov 2004). This method
therefore provides reliable evidence regarding the nutritional
signiﬁcance of paracellular absorption (e.g., the proportional
contribution of paracellular to total glucose uptake). Calcula-
tions by this method can also be made with relatively few
assumptions about kinetics of elimination or number of dis-
tribution pools (Welling 1986). Elimination of nonmetabolized
probes (e.g., l-glucose and the actively transported glucose an-
alogue 3-O-methyl-d-glucose) is by renal ﬁltration,andbecause
probe concentration is measured directly in blood, plasma
marker concentration is inﬂuenced primarily by glomerular
ﬁltration rate (GFR). However, the disadvantage is that the
protocol requires repeated blood samples to be collected over
a relatively short time period.
The steady state feeding pharmacokinetic protocol, with
probe elimination determined based on concentration in ex-
creta, was validated by Karasov and Cork (1994) so that itcould
be applied in small birds, from which multiple blood samples
cannot be drawn. This has proven to be a distinct advantage
of this protocol, and it has been widely applied recently
(McWhorter and Martı ´nez del Rio 1999; McWhorter et al.
2003, 2004, 2006; Hartman Bakken et al. 2004; Hartman Bak-
ken and Sabat 2006; Napier et al. 2008b). Another advantage
is that this method may be used to study the effects of diet
energy density on the extent of paracellular absorption. For
example, recent studies using steady state feeding methods in
hummingbirds (McWhorter et al. 2006), honeyeaters, and sun-
birds (Napier et al. 2008b) have shown that l-glucose bio-
availability increases with an increase in diet energy density,
most likely related to a concomitant increase in digesta reten-
tion time (Lopez-Calleja et al. 1997).
Where animals are too small to withstand repeated blood
sampling, the fractional rate of elimination of the probe from
plasma has been estimated by its appearance in excreta. The
primary assumption of this method is that the rate of loss of
marker from plasma equals that of its appearance in excreta.
Karasov and Cork (1994) showed that this was the case in
nectarivorous rainbow lorikeets by sampling both blood and
excreta in the same birds simultaneously after probe injection.
Estimates of Kel in our study were higher for the steady state
feeding protocol (cf. values for the AUC protocol in table 1),
revealing a faster rate of appearance of the probe in excreta
than predicted from its removal from the bloodstream estab-
lished via the AUC pharmacokinetic protocol. That is, red wat-
tlebirds handle and eliminate l-glucose faster when feeding at
a steady rate than under the AUC protocol (where they had
feed withdrawn 20 min before the experiment and fed very
little during the ﬁrst hour of the experiment). Elimination of
l-glucose in the steady state feeding protocol (based on ap-
pearance of marker in excreta) is inﬂuenced by GFR, renal
fractional water recovery (FWR), and rate of digesta passing
through the intestine (McWhorter et al. 2003). FWR is re-
sponsive to reduced water intake rate in red wattlebirds (Gold-
stein and Bradshaw 1998) and other nectarivorous birds (Hart-
man Bakken et al. 2004; McWhorter et al. 2004) while GFR
has been shown to be responsive to more extensive watershort-
age (e.g., due to nocturnal fasting) in hummingbirds (Hartman
Bakken et al. 2004; Hartman Bakken and Sabat 2006); renal
function in the nectarivorous birds studied to date may there-
fore be slowed or completely stop in response to reduced food
(i.e., water) intake. When the birds are feeding ad lib. (i.e.,
under the steady state feeding protocol), they rapidly eliminate
waste materials through their kidneys, but when they are not
feeding, it is likely that there is reduction or suspension of renal
function. It is therefore not surprising that the estimated rate
of loss of marker from plasma, calculated when the birds are
not feeding, does not match its appearance in excreta calculated
when they are feeding ad lib.
Because of differences in estimations of Kel, S estimates de-
rived through the steady state feeding protocol (8.75%
of body mass) were considerably lower than those esti- 5.4%
mated through the AUC pharmacokinetic protocol
( of body mass) and also lower than previously 19.67%3.01%
reported (∼20%–25% of body mass) for several other avian
species over a range of body mass (Karasov and Cork 1994;
Levey and Cipollini 1996; Aﬁk et al. 1997; Hartman Bakken et
al. 2004). Therefore, the low values of S estimates as a per-
centage of body mass are considered to be suspect. Distribution
pool size estimates rely on estimates of Kel, and therefore the
discrepancy in values for S are likely to similarly reﬂect renal
function, potential postrenal modiﬁcation of urine, and mixing
of intestinal contents with urine.
The calculation of bioavailability relies heavily on estimates
of Kel and consequently S, and we have demonstrated thatthese
measures are extremely sensitive to the mathematical method
used to calculate them. Standard pharmacokinetic methods
suggest that these values should be calculated from the rela-
tionship of ln-transformed values of probe concentration (in
plasma or excreta) against time, and we believe that this is the
most robust and objective approach to ﬁtting mathematical
functions to these types of data, especially when obtained from
probe appearance in excreta. However, for the steady statefeed-
ing method, these calculations resulted in differing estimates
of Kel and consequently S that were around half those estimated
by the AUC method. Nonlinear model ﬁtting to raw (i.e., not
ln-transformed) values results in greater error in the estimates
of Kel and S. A large proportion of this discrepancy apparently
results from the ﬁrst data points (i.e., the ﬁrst few excreta
collected once the animal is returned to its cage to feed), since
elimination of those data with high Ci values (where the dif-
ference betweenconsecutiveexcretaconcentrationswereatleast
ﬁve times higher than the differences between subsequent dataTechnical Comment 207
points) resulted in estimates of Kel and S that were more similar
to those derived using the AUC protocol. The steady state
pharmacokinetic protocol is sensitive to the assumption that
animals are feeding in steady state with regard to probe ab-
sorption and elimination. Some individuals did not return to
feed immediately after they had been handled for injections,
violating the assumption of steady state feeding, and conse-
quently they displayed a reduced excretion rate for up to 40
min after return to cages. If possible, future studies should take
care to record the time at which animals return to feeding,
which may allow consideration of whether an individual vio-
lates the assumption of steady state feeding.
Finally, these pharmacokinetic mathematical calculations as-
sume that elimination follows single-compartmentkinetics,de-
picting the body as a single, kinetically homogenous unit
(Gibaldi and Perrier 1982). The assumption of single-com-
partment elimination kinetics appears to be valid for elimi-
nation of l-glucose based on concentration in both excreta and
plasma for all species studied to date. Further, Karasov and
Cork (1994) argued that changing the assumption about the
number of compartments that inﬂuence probe elimination
tends to cause counterbalancing changes in the slope (elimi-
nation rate constant, Kel) and intercept (inverse of distribution
pool size S, when concentrations are dose corrected), so neither
pharmacokinetic method is especially sensitive to deviations to
this assumption.
Conclusions
Our results highlight the sensitivity of the steady state feeding
pharmacokinetic protocol to violations of its primary assump-
tion that birds are feeding in a steady state. The validity of
assumptions associated with these protocols is critical in the
calculation of pharmacokinetic parameters and, as such, need
to be addressed when planning experiments and interpreting
results. The use of mathematical models requiring assumptions
that may be difﬁcult to justify should be reconsidered wherever
possible (Wade 1985). It is not possible to compare the two
methods for every new species (e.g., where the animal is too
small to take repeated blood samples from), and we are not
suggesting that this is required. However, acknowledgment of
the limitations and validations of these two pharmacokinetic
protocols will be an important step toward collectingvaliddata,
while understanding these limitations will ensure that research-
ers carefully consider their experimental design. It is difﬁcult
to determine the magnitude of the potential margin of error
across studies, since this is likely to vary greatly between species
according to their responses to the different experimental
protocols.
Each method has advantages and disadvantages, and these
will be important in determining the experimental design se-
lected for future studies. The standard pharmacokinetic AUC
protocol provides the most robust estimates of bioavailability
because it relies on fewer assumptions and also has the advan-
tage of allowing calculation of probe absorptionrates.However,
because the birds do not feed ad lib. during the experiment, it
should be recognized that potential changes in renal function
may inﬂuence the estimates derived through this process. This
is therefore not particularly useful for species that may shut
down GFR during times of not feeding (e.g., nectarivorous
species) because the data collected are not likely to reﬂect how
the animals would cope with their diet under natural
conditions.
On the other hand, the steady state feeding protocol provides
estimates in unrestrained birds that are feeding ad lib. (assum-
ing this condition can be met) and allows exploration of the
effects of nutrient concentration and osmolality on paracellular
permeability and nutrient uptake. The problem of how and
when animals recommence feeding after disturbance plays a
signiﬁcant role in altering the initial data points collected and
therefore estimates of Kel and S. Habituating individual animals
to handling may serve to reduce some of these issues, although
we have found that some individuals,despiterepeatedattempts,
still do not recommence feeding within sufﬁcient time to yield
reliable estimates (silvereyes Zosterops lateralis; K. Napier, un-
published data). It is probably advisable, therefore, to eliminate
such individuals from further analyses since they do not yield
physiologically relevant data. Species that naturally have a low
food intake rate may be less likely to violate the conditions of
steady state feeding than animals with a high food intake rate
(although they would likely yield more variable data if the
conditions of steady state feeding were not adequately met).
Both protocols, therefore, havetheiradvantagesandapplication
in the study of digestive physiology.
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